#indiacancercare
Russia’s Enteromix Cancer Vaccine Shows 100% Efficacy In Early Trials
Russia has taken a major step in the global fight against cancer with the announcement of Enteromix, a new mRNA-based cancer vaccine that has shown 100% efficacy and safety in early human trials. Developed by the National Medical Research Radiological Centre and the Engelhardt Institute of Molecular Biology, Enteromix was tested on 48 patients with colorectal cancer. The results revealed tumour shrinkage and zero serious side effects, positioning this innovatio
Russia’s Enteromix Cancer Vaccine Shows 100% Efficacy In Early Trials
Russia has taken a major step in the global fight against cancer with the announcement of Enteromix, a new mRNA-based cancer vaccine that has shown 100% efficacy and safety in early human trials. Developed by the National Medical Research Radiological Centre and the Engelhardt Institute of Molecular Biology, Enteromix was tested on 48 patients with colorectal cancer. The results revealed tumour shrinkage and zero serious side effects, positioning this innovatio









